Marks Gilbert Lynn
Reporting owner on Forms 3, 4 and 5, CIK 1916940.
Marks Gilbert Lynn reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ANTX · AN2 Therapeutics, Inc.CIK 1880438 | director | 1 | 2026-10-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ANTX · AN2 Therapeutics, Inc.Common Stock | 2026-10-12 | A granted | +2,283 | $0 | 84,156 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-420643 | AN2 Therapeutics, Inc. | 2026-10-13 |